银屑病对医疗保健费用和患者工作损失的影响。
The impact of psoriasis on health care costs and patient work loss.
作者信息
Fowler Joseph F, Duh Mei Sheng, Rovba Ludmila, Buteau Sharon, Pinheiro Lisa, Lobo Francis, Sung Jennifer, Doyle Joseph J, Swensen Andrine, Mallett David A, Kosicki George
机构信息
University of Louisville, Louisville, Kentucky, USA.
出版信息
J Am Acad Dermatol. 2008 Nov;59(5):772-80. doi: 10.1016/j.jaad.2008.06.043.
BACKGROUND
There are few comprehensive estimates of the cost of psoriasis in the United States.
OBJECTIVE
We sought to quantify the incremental direct medical and indirect work loss costs associated with psoriasis.
METHODS
A de-identified claims database from 31 self-insured employers during the period 1998 to 2005 was used. Patients with at least two psoriasis diagnosis claims (N = 12,280) were compared with 3 control subjects (matched on year of birth and sex) without psoriasis. Multivariate two-part regression analysis was used to isolate the incremental cost of psoriasis by controlling for comorbidities and other confounding factors.
RESULTS
After multivariate adjustment, the incremental direct and indirect costs of psoriasis were approximately $900 and $600 (P < .001) per patient per year, respectively.
LIMITATIONS
The database used in this study does not contain information on patient out-of-pocket costs or loss of productivity costs at work.
CONCLUSION
The incremental cost of psoriasis is approximately $1500 per patient per year, with work loss costs accounting for 40% of the cost burden.
背景
美国对银屑病成本的综合估算较少。
目的
我们试图量化与银屑病相关的增量直接医疗成本和间接工作损失成本。
方法
使用了1998年至2005年期间来自31家自我保险雇主的去识别化索赔数据库。将至少有两项银屑病诊断索赔的患者（N = 12,280）与3名无银屑病的对照对象（按出生年份和性别匹配）进行比较。采用多变量两部分回归分析，通过控制合并症和其他混杂因素来分离银屑病的增量成本。
结果
经过多变量调整后，银屑病的增量直接成本和间接成本分别约为每年每位患者900美元和600美元（P < .001）。
局限性
本研究中使用的数据库不包含患者自付费用或工作中生产力损失成本的信息。
结论
银屑病的增量成本约为每年每位患者1500美元，工作损失成本占成本负担的40%。
Zotero 插件